These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 7595374)

  • 1. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
    Sjöblom A; Nerstedt A; Jansson A; Rymo L
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter.
    Sjöblom A; Jansson A; Yang W; Laín S; Nilsson T; Rymo L
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2679-92. PubMed ID: 7595375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
    Johannsen E; Koh E; Mosialos G; Tong X; Kieff E; Grossman SR
    J Virol; 1995 Jan; 69(1):253-62. PubMed ID: 7983717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit.
    Ning S; Hahn AM; Huye LE; Pagano JS
    J Virol; 2003 Sep; 77(17):9359-68. PubMed ID: 12915551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
    Laux G; Dugrillon F; Eckert C; Adam B; Zimber-Strobl U; Bornkamm GW
    J Virol; 1994 Nov; 68(11):6947-58. PubMed ID: 7933076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus nuclear antigen 2-estrogen receptor fusion proteins transactivate viral and cellular genes and interact with RBP-J kappa in a conditional fashion.
    Kempkes B; Pawlita M; Zimber-Strobl U; Eissner G; Laux G; Bornkamm GW
    Virology; 1995 Dec; 214(2):675-9. PubMed ID: 8553575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
    Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD
    J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.
    Pegman PM; Smith SM; D'Souza BN; Loughran ST; Maier S; Kempkes B; Cahill PA; Simmons MJ; Gélinas C; Walls D
    J Virol; 2006 Aug; 80(16):8133-44. PubMed ID: 16873269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters.
    Groves AK; Cotter MA; Subramanian C; Robertson ES
    J Virol; 2001 Oct; 75(19):9446-57. PubMed ID: 11533207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element.
    Laux G; Adam B; Strobl LJ; Moreau-Gachelin F
    EMBO J; 1994 Dec; 13(23):5624-32. PubMed ID: 7988559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA.
    Waltzer L; Perricaudet M; Sergeant A; Manet E
    J Virol; 1996 Sep; 70(9):5909-15. PubMed ID: 8709211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements.
    Waltzer L; Logeat F; Brou C; Israel A; Sergeant A; Manet E
    EMBO J; 1994 Dec; 13(23):5633-8. PubMed ID: 7988560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa.
    Strobl LJ; Höfelmayr H; Stein C; Marschall G; Brielmeier M; Laux G; Bornkamm GW; Zimber-Strobl U
    Immunobiology; 1997 Dec; 198(1-3):299-306. PubMed ID: 9442401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.
    Henkel T; Ling PD; Hayward SD; Peterson MG
    Science; 1994 Jul; 265(5168):92-5. PubMed ID: 8016657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa.
    Bourillot PY; Waltzer L; Sergeant A; Manet E
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():363-70. PubMed ID: 9472621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of a consensus AP-2 regulatory sequence within the Epstein-Barr virus LMP1 promoter in EBNA2 mediated transactivation.
    Jansson A; Johansson P; Yang W; Palmqvist L; Sjöblom-Hallén A; Rymo L
    Virus Genes; 2007 Oct; 35(2):203-14. PubMed ID: 17546492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation.
    Fuentes-Pananá EM; Ling PD
    J Virol; 1998 Jan; 72(1):693-700. PubMed ID: 9420275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
    Yalamanchili R; Tong X; Grossman S; Johannsen E; Mosialos G; Kieff E
    Virology; 1994 Nov; 204(2):634-41. PubMed ID: 7941331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator.
    Marshall D; Sample C
    J Virol; 1995 Jun; 69(6):3624-30. PubMed ID: 7745710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.